Clinical Trial Update: Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating radiolabeled monoclonal antibody therapy given after radiation in patients with primary brain tumors; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Neuroblastoma

Snippet

Sponsor: Darell D. Bigner, MD, PhD | Conditions: Brain and Central Nervous System Tumors, Neuroblastoma | Phase 1 | Status: COMPLETED